Define health technology assessment (HTA) and its role in policy decisions about new medicines and devices.

• A. HTA evaluates value, safety, efficacy, and cost-effectiveness to guide coverage and pricing decisions.
• B. HTA is the clinical trial process used to test new therapies before approval.
• C. HTA only assesses the regulatory compliance of medical devices.
• D. HTA focuses on hospital administration efficiency rather than patient outcomes.

Answer: (B)

Health technology assessment is a structured, evidence-based evaluation of a health technology’s value and impact. It examines how well a medicine or device works in practice (clinical effectiveness), its safety, and its costs, including cost-effectiveness and the potential budget impact. It also considers organizational, ethical, and social implications and how the technology fits within a health system. The aim is to inform policy decisions about whether to cover or reimburse the technology, at what price, and how it should be used in practice. HTA relies on evidence from clinical studies and real-world data, often incorporating economic modeling and scenarios. It is separate from the clinical trial process and regulatory approval, which generate evidence; HTA interprets that evidence to guide access and payment decisions.